Reactions of reactive metabolites with hemoproteins-toxicological implications: Covalent alteration of hemoproteins

Advances in Experimental Medicine and Biology

Volumn 387, Issue , 1996, Pages 37-45

  Osawa, Yoichi ^a   Nakatsuka, Kashime ^a   Williams, Mark S ^b   Kindt, James T ^a   Nakatsuka, Mikiya ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BROMOTRICHLOROMETHANE; CYTOCHROME P450; DEXTRO ARGININE; HEMOGLOBIN; HEMOPROTEIN; HYDROGEN PEROXIDE; MYOGLOBIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; XENOBIOTIC AGENT;

CONFERENCE PAPER; HEART MUSCLE ISCHEMIA; HEMOLYSIS; HUMAN; HUMAN CELL; METABOLISM; PRIORITY JOURNAL; REPERFUSION INJURY; TOXICOLOGY;

EID: 0029782103     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9480-9_6     Document Type: Conference Paper

References (35)

1. Arduini, A., Mancinelli, G., Radatti, G.L., Damonti, W., Hochstein, P., & Cadenas. E. (1992). Reduction of sperm whale ferrylmyoglobin by endogenous reducing agents: Potential reducible loci of ferrylmyoglobin. Free Radical Biology and Medicine, 13, 449-454.
2. Arduini, A., Eddy, L., & Hochstein, P. (1990). Detection of ferryl myoglobin in the isolated ischemic rat heart. Free Radical Biology and Medicine, 9, 511-513.
3. Brodie, B.B., Reid, W.D., Cho, A.K., Sipes, I.G., Krishna, G., & Gillette, J.R. (1971). Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A, 68, 160-164.
4. Bryant, M.S., Skipper, P.L., Tannenbaum, S.R., & Maclure, M. (1987). Hemoglobin adducts of 4-amino-biphenyl in smokers and nonsmokers. Cancer Research, 47, 602-608.
5. Catalano, C.E., Choe, Y.S., & Ortiz de Montellano, P.R. (1989). Reactions of the protein radical in peroxide-treated myoglobin: Formation of a heme-protein cross-link. Journal of Biological Chemistry, 264, 10534-10541.
6. Galaris, D., Cadenas, E., & Hochstein, P. (1989). Redox cycling of myoglobin and ascorbate: A potential protective mechanism against oxidative reperfusion injury in muscle. Arch Biochem Biophys, 273, 497-504.
7. Gorelick, N.J., Hutchins, D.A., Tannenbaum, S.R., & Wogan, G.N. (1989). Formation of DNA and hemoglobin adducts of fluoranthene after single and multiple exposures. Carcinogenesis, 10, 1579-1587.
8. Halpert, J. (1982). Further studies of the suicide inactivation of purified rat liver cytochrome p-450 by chloramphenicol. Mol Pharmacol, 21, 166-172.
9. Halpert, J., Miller, N.E., & Gorsky, L.D. (1985). On the mechanism of the inactivation of the major phenobarbital-inducible isozyme of rat liver cytochrome P-450 by chloramphenicol. Journal of Biological Chemistry, 260, 8397-8403.
10. Halpert, J.R. & Stevens, J.C. (1991). Cytochrome P-450 as a target of biological reactive intermediates. Adv Exp Med Biol, 283, 105-109.
11. Haugen, D.A. (1989). Charge-shift strategy for isolation of hemoglobin-carcinogen adducts formed at the β93 cysteine sulfhydryl groups. Chemical Research in Toxicology: 2, 379-385.
12. Hinson, J.A. & Roberts, D.W. (1992). Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. Annu Rev Pharmacol Toxicol, 32, 471-510.
13. 3 : Cross-linking of heme to cysteine residue 93. Journal of Biological Chemistry, 267, 8739-8743.
14. McMillan, K., Bredt, D.S., Hirsch, D.J., Snyder, S.H., Clark, J.H., & Masters, B.S.S. (1992). Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci U S A, 89, 11141-11145.
15. G-methyl-L-arginine: evidence for protein modification and heme loss. Biochemistry. In press.
16. Ortiz de Montellano, P.R. (1990). Free radical modification of prosthetic heme groups. Pharmacol.Ther., 48, 95-120.
17. Ortiz de Montellano, P.R. & Correia, M.A. (1983). Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol, 23, 481-503.
18. Osawa, Y., Fellows, C., Meyer, C.M., Woods, A., Castoro, J.A., Cotter, R.J., Wilkins, C., & Highet, R.J. (1994). Structure of the novel heme adduct formed during the reaction of human hemoglobin with BrCCl3 in red cell lysates. Journal of Biological Chemistry, 269, 15481-15487.
19. Osawa, Y., Darbyshire, J.F., Meyer, C.M., & Alayash, A.I. (1993). Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Biochem Pharmacol, 12, 2299-2305.
20. 3 and molecular modeling of the oxidase form. Journal of Biological Chemistry, 268, 2953-2959.
21. Osawa, Y. & Davila, J.C. (1993). Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem Biophys Res Commun, 194, 1435-1439.
22. Osawa, Y., Davila, J.C., Meyer, C.M. & Nakatsuka, M. (1994). Mechanism based inactivation of nitric oxide synthase, a P450-like enzyme, by xenobiotics. In M.C. Lechner (Ed.). Cytochrome P-450: biochemistry, biophysics, and molecular biology pp. 459-462. John Libbey Eurotext, Paris.
23. Osawa, Y., Fellows, C. & Highet, R.J. (1992). Use of stable and radioactive isotopes to identify reactive metabolites and target macromolecules associated with toxicities of halogenated hydrocarbons. In E. Buncel & G.W. Kabalka (Eds.). Syntheses and application of isotopically labelled compounds 1991, proceeding of the fourth international symposium, Toronto, Canada pp. 415-420. Elsevier Science, Amsterdam.
24. 3: Covalent bonding of the proximal histidine to the ring I vinyl group. Journal of Biological Chemistry, 266, 3208-3214.
25. Osawa, Y. & Korzekwa, K. (1991). Oxidative modification by low levels of HOOH can transform myoglobin into an oxidase. Proc Natl Acad Sci USA, 88, 7081-7085.
26. Osawa, Y. & Pohl, L.R. (1989). Covalent bonding of the prosthetic heme to protein: A potential mechanism for the suicide inactivation or activation of hemoproteins. Chemical Research in Toxicology, 2, 131-141.
27. Rachmilewitz, E.A. (1974). Denaturation of the normal and abnormal hemoglobin molecule. Seminars in Hematology, 11, 441-462.
28. Roberts, E.S., Hopkins, N.E., Zaluzec, E.J., Gage, D.A., Alworth, W.L., & Hollenberg, P.F. (1994). Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Biochemistry, 33, 3766-3771.
29. Roberts, E.S., Hopkins, N.E., Alworth, W.L., & Hollenberg, P.F. (1993). Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: Identification of an active-site peptide. Chemical Research in Toxicology, 6, 470-479.
30. Stuehr, D.J. & Ikeda-Saito, M. (1992). Spectral characterization of brain and macrophage nitric oxide synthases. Journal of Biological Chemistry, 267, 20547-20550.
31. 2-mediated cross-linking of sperm whale myoglobin. Journal of Biological Chemistry, 263, 17880-17886.
32. White, K.A. & Marletta, M.A. (1992). Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry, 31, 6627-6631.
33. Winslow, R.M. (1992). Hemoglobin-based red cell substitutes. The Johns Hopkins University Press. Baltimore.
34. Winterbourn, C.C. (1990). Oxidative denaturation in congenital hemolytic anemias: The unstable hemoglobins. Seminars in Hematology, 27, 41-50.
35. Yao, K., Falick, A.M., Patel, N., & Correia, M.A. (1993). Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide. Journal of Biological Chemistry, 268, 59-65.